leading brands of glp-1 agonists in biopharma Glucagon-like Peptide-1 (GLP-1) Market Size and Companies GLP-1 Agonists Market Report 2025-2033,

Del Prato S, Kahn SE, Pavo I, Weerakkody GJ, Yang Z, Doupis J, Aizenberg D, Wynne AG, Riesmeyer JS, Heine RJ, et al

KFF Health News is a national newsroom that produces in-depth journalism about health issues.

This discussion should consider the individual's overall health, risk factors, and therapeutic options to make an informed decision about whether to continue or discontinue GLP-1 drugs

"Safety and Efficacy of Omarigliptin (MK-3102), a Novel Once-Weekly DPP-4 Inhibitor for the Treatment of Patients With Type 2 Diabetes"

10.1016/j.jamda.2016.04.016 156 RodbardH

The glucagon component aids the body in burning stored energy, primarily from fat, rather than retaining it